2-[4-[(4-amino-3-phenylpyrazolo[3,4-d]pyrimidin-1-yl)methyl]triazol-1-yl]-1-(4-methylphenyl)ethanone
C23H20N8O — CID 53322860
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-[(4-amino-3-phenylpyrazolo[3,4-d]pyrimidin-1-yl)methyl]triazol-1-yl]-1-(4-methylphenyl)ethanone
2-[4-[(4-amino-3-phenylpyrazolo[3,4-d]pyrimidin-1-yl)methyl]triazol-1-yl]-1-(4-methylphenyl)ethanone (PubChem CID 53322860) has the molecular formula C23H20N8O and a molecular weight of 424.47 g/mol. Its IUPAC name is 2-[4-[(4-amino-3-phenylpyrazolo[3,4-d]pyrimidin-1-yl)methyl]triazol-1-yl]-1-(4-methylphenyl)ethanone.
Molecular Properties
| Compound Name | 2-[4-[(4-amino-3-phenylpyrazolo[3,4-d]pyrimidin-1-yl)methyl]triazol-1-yl]-1-(4-methylphenyl)ethanone |
|---|---|
| PubChem CID | 53322860 |
| Molecular Formula | C23H20N8O |
| Molecular Weight | 424.47 g/mol |
| Exact Mass | 424.18 |
| IUPAC Name | 2-[4-[(4-amino-3-phenylpyrazolo[3,4-d]pyrimidin-1-yl)methyl]triazol-1-yl]-1-(4-methylphenyl)ethanone |
| SMILES | Cc1ccc(C(=O)Cn2cc(Cn3nc(-c4ccccc4)c4c(N)ncnc43)nn2)cc1 |
| InChI | InChI=1S/C23H20N8O/c1-15-7-9-16(10-8-15)19(32)13-30-11-18(27-29-30)12-31-23-20(22(24)25-14-26-23)21(28-31)17-5-3-2-4-6-17/h2-11,14H,12-13H2,1H3,(H2,24,25,26) |
| InChIKey | UOINOEXGVIMYLU-UHFFFAOYSA-N |
| XLogP | 2.91 |
| TPSA | 117.40 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 424.47 |
| LogP ≤ 5 | 2.91 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 53322860 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.